查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1699460

全球链球菌感染疾病治疗市场按治疗类型、给药途径、疾病类型、通路和地区划分

Global Strep Throat Treatment Market, By Treatment Type, By Route of Administration, By Disease Type, BY Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球感染疾病治疗市场规模为 20.8 亿美元，到 2032 年将达到 28.5 亿美元，2025 年至 2032 年的复合年增长率为 4.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 20.8亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 4.60% 2032年价值预测 28.5亿美元
数字。 2025年全球市场占有率链球菌感染疾病治疗市场各地区份额（%）
全球链球菌性咽喉炎治疗市场-IMG1

链球菌是由 A 型链球菌 (GAS)感染疾病的细菌感染疾病，会导致喉咙和扁桃体发炎和疼痛。感染疾病在 5 至 15 岁的儿童中特别常见。根据 2022 年成立的研究机构拉霍亚免疫学研究所最近的估计，链球菌性感染疾病每年影响全球超过 6 亿人。如果不及时治疗，它会导致各种其他严重的健康併发症，如风湿热和肾臟疾病。目前的感染疾病感染治疗市场依赖青霉素和阿莫西林等抗生素药物。然而，抗生素抗药性的增加带来了重大挑战。因此，製药公司正致力于开发新药和治疗方法，以有效控制链球菌感染疾病。

市场动态：

全球链球菌感染疾病治疗市场的成长是由全球链球菌感染疾病盛行率的增加所推动的。据估计，光是在美国，每年就有超过 1,800 万例链球菌性咽喉炎感染疾病。此外，人们健康意识的增强和非处方药的易得性也推动了市场的成长。然而，大多数链球菌感染疾病都是自限性的，这可能会限制市场潜力。此外，替代治疗方法的开发需要较长的开发週期和较高的投资成本，这阻碍了创新研究活动。此外，非专利抗生素市场已经饱和，进一步限制了强劲产生收入的机会。儘管如此，市场上仍有机会透过新的药物输送技术和针对链球菌感染疾病的疫苗来满足未满足的需求。

大众的健康意识日益增强，越来越多的人寻求及时的医疗建议和治疗，以缓解症状并预防风湿热等併发症。透过改善医疗保健服务和资讯资源，可以进一步加强人们的这种认识，从而促进及时治疗链球菌感染疾病。非处方药（OTC）是症状管理的首选，并推动了 OTC 市场的发展。这些药物的随时可用可以为患者提供与链球菌性感染疾病相关的咽喉痛症状的即时缓解，从而促进整个市场的成长。然而，由于大多数链球菌感染疾病具有自限性，症状无需治疗即可消退，因此患者可能会选择家庭治疗方法或放弃药物干预，从而阻碍市场成长潜力。开发链球菌咽头炎的新治疗方法是一项昂贵且耗时的工作，通常需要很长的开发週期。高昂的投资成本可能会阻碍力创新研究和药物开发。然而，针对病原体 A 型链球菌的药物输送机制和疫苗的开发有市场机会。新的药物配方和输送技术可以提高治疗效果和可用性，疫苗有可能显着降低感染疾病的发生率。我们还能够引入快速诊断工具，以便早期准确地发现咽部链球菌感染疾病，从而采取适当的治疗性介入并减少不必要的抗生素使用。

例如，2021 年 9 月，製药公司林肯製药宣布收购位于梅赫萨纳的一家工厂，该工厂生产用于治疗肺炎和支气管炎等疾病的抗生素。

本研究的主要特点

  • 本报告对全球链球菌感染疾病治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了不同领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球链球菌感染疾病治疗市场的主要企业概况。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球链球菌感染疾病治疗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球链球菌感染疾病治疗市场的各种策略矩阵轻鬆做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球链球菌感染疾病治疗市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球链球菌感染疾病治疗市场（依治疗类型）

  • 抗生素
  • 阿莫西林
  • 青霉素
  • 其他的
  • 止痛药
  • 其他的

6. 2020 年至 2032 年按给药途径分類的全球链球菌感染疾病治疗市场

  • 口服
  • 局部的
  • 注射

7. 2020 年至 2032 年全球链球菌感染疾病治疗市场（依疾病类型）

  • 急性链球菌咽头炎
  • 咽头炎
  • 扁桃腺炎
  • 喉炎
  • 其他的

8. 2020 年至 2032 年全球链球菌感染疾病治疗市场（依通路划分）

  • 医院药房
  • 零售药局
  • 网路药局

9. 2020 年至 2032 年全球链球菌感染疾病治疗市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十章 竞争格局

  • Pfizer Inc.
  • Sanofi
  • Astrazeneca
  • Novartis AG
  • Bayer AG
  • GSK plc
  • Melinta Therapeutics
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Merck & co, Inc.
  • Johnson & Johnson Service, Inc.
  • Accord Healthcare
  • Amneal Pharmaceuticals LLC.
  • MiddleBrook Pharmaceuticals, Inc.
  • Taiho Pharmaceutical Co., Ltd

第 11 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6635

Global Strep Throat Treatment Market is estimated to be valued at USD 2.08 Bn in 2025 and is expected to reach USD 2.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.08 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.60% 2032 Value Projection: USD 2.85 Bn
Figure. Global Strep Throat Treatment Market Share (%), By Region 2025
Global Strep Throat Treatment Market - IMG1

Strep throat is a bacterial infection caused by Group A Streptococcus (GAS) that results in an inflammation and soreness of the throat and tonsils. It is a very common infectious disease, especially among children aged 5-15 years. According to recent estimates provided by La Jolla Institute for Immunology, a research institute in 2022, strep throat affects over 600 million people globally each year. If left untreated, it can lead to various other severe health complications like rheumatic fever and kidney disease. The current market for strep throat treatment relies on antibiotic medications like penicillin and amoxicillin to clear the bacterial infection. However, increasing antibiotic resistance is posing a major challenge. As a result, pharmaceutical companies are focusing on developing new drugs and treatment options to effectively manage strep throat infections.

Market Dynamics:

Global strep throat treatment market growth is driven by rising prevalence of Strep throat infections worldwide. It is estimated that over 18 million cases of Strep throat occur in the U.S. alone each year. The market growth is also boosted by growing health awareness and easy availability of over-the-counter treatment drugs. However, the market potential can be restricted due to the self-limiting nature of most strep throat infections. Developing alternative treatment approaches also involves long development cycles and high investment costs which hinders innovative research activities. Moreover, market saturation of generic antibiotic drugs further limits robust revenue generation opportunities. Nevertheless, the market is presented with opportunities to address the unmet needs through novel drug delivery technologies and vaccines against Strep throat.

Health awareness among the general populace has increased, with more people seeking prompt medical advice and treatment for symptomatic relief and to prevent complications such as rheumatic fever. This awareness is bolstered by greater access to healthcare services and information resources that encourage timely treatment of Strep throat. Over-the-counter (OTC) medications serve as an initial resort for symptom management, driving the OTC segment of the market. The easy availability of these drugs contributes to the overall market growth, providing patients with immediate access to relief from sore throat symptoms associated with Strep infections. However, the inherent self-limiting nature of most Strep throat infections, where symptoms resolve without treatment, can impede market growth potential as individuals may opt for home remedies or choose not to pursue pharmaceutical interventions. Developing new and improved treatments for Strep throat can be a costly and time-intensive endeavor, often marked by long development cycles. High investment costs can act as a deterrent for innovative research and drug development. Yet, opportunities within the market lie in the advancement of drug delivery mechanisms and the development of vaccines against the causative bacteria, Group A Streptococcus. Novel drug formulations and delivery technologies can enhance treatment efficacy and user experience, while vaccines could significantly reduce the incidence of infections. The market is also ready for the introduction of rapid diagnostic tools, which could facilitate early and accurate detection of Strep throat infections, allowing for appropriate treatment interventions and reducing unnecessary use of antibiotics.

For instance, in September 2021, Lincoln Pharmaceuticals Ltd, a pharmaceutical company, announced the acquisition of facility in Mehsana that makes antibiotics used in the treatment of pneumonia and bronchitis, among other ailments.

Key features of the study:

  • This report provides in-depth analysis of the global strep throat treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global strep throat treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc., Sanofi, Astrazeneca, Novartis AG, Bayer AG, GSK plc, Melinta Therapeutics, Amgen Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Merck & co, Inc., Johnson & Johnson Service, Inc., Accord Healthcare, Amneal Pharmaceuticals LLC., MiddleBrook Pharmaceuticals, Inc., and Taiho Pharmaceutical Co., Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global strep throat treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global strep throat treatment market

Global Strep Throat Treatment Market- Segmentation

  • By Treatment Type
    • Antibiotics
    • Amoxicillin
    • Penicillin
    • Others
    • Pain Relievers
    • Others
  • By Route of Administration
    • Oral
    • Topical
    • Injectable
  • By Disease Type
    • Acute Strep Throat
    • Pharyngitis
    • Tonsillitis
    • Laryngitis
    • Others
  • By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.
    • Sanofi
    • Astrazeneca
    • Novartis AG
    • Bayer AG
    • GSK plc
    • Melinta Therapeutics
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Merck & co, Inc.
    • Johnson & Johnson Service, Inc.
    • Accord Healthcare
    • Amneal Pharmaceuticals LLC.
    • MiddleBrook Pharmaceuticals, Inc.
    • Taiho Pharmaceutical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Strep Throat Treatment Market, By Treatment Type
    • Global Strep Throat Treatment Market, By Route of Administration
    • Global Strep Throat Treatment Market, By Disease Type
    • Global Strep Throat Treatment Market, By Distribution Channel
    • Global Strep Throat Treatment Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Rising prevalence of streptococcal infections
    • Increasing awareness about streptococcal infections
    • Growing investments in research and development (R&D)
    • Government support and initiatives
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Strep Throat Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Strep Throat Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Amoxicillin
  • Penicillin
  • Others
  • Pain Relievers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Strep Throat Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Strep Throat Treatment Market, By Disease Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Acute Strep Throat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Pharyngitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Tonsillitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Laryngitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Strep Throat Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospital Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Retail Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Online Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Strep Throat Treatment Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032 ,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Astrazeneca
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GSK plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Melinta Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & co, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Johnson & Johnson Service, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Accord Healthcare
  • Amneal Pharmaceuticals LLC.
  • MiddleBrook Pharmaceuticals, Inc.
  • Taiho Pharmaceutical Co., Ltd
  • Analyst Views

11. Section

  • Research Methodology
  • About us